AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
6.27
+0.23 (3.81%)
Sep 3, 2026, 1:03 PM EDT - Market open
AdaptHealth Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, AdaptHealth stock has a consensus rating of "Strong Buy" and an average price target of $9.14. The average 1-year stock price forecast is 45.77% higher than the current stock price, while the lowest is $7.00 (+11.64%) and the highest is $10 (+59.49%).
Price Target: $9.14 (+45.77%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AdaptHealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Reiterates $9 | Buy | Reiterates | $9 | +43.54% | Aug 25, 2026 |
| UBS | UBS | Buy Reiterates $10 | Buy | Reiterates | $10 | +59.49% | Aug 24, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $10 | Buy | Maintains | $10 | +59.49% | Aug 12, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $15 → $8 | Buy | Reiterates | $15 → $8 | +27.59% | Aug 6, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $15 → $10 | Buy | Maintains | $15 → $10 | +59.49% | Aug 5, 2026 |
Financial Forecast
Revenue This Year
2.88B
from 3.24B
Decreased by -11.32%
Revenue Next Year
2.99B
from 2.88B
Increased by 3.80%
EPS This Year
-0.45
from 0.54
EPS Next Year
-0.13
from -0.45
EPS and Forward PE are based on non-GAAP adjusted numbers.